Are Oxygenta Pharma latest results good or bad?
Oxygenta Pharma's latest results show strong sales growth of 368.91% year-on-year, reaching Rs 49.47 crore, but the company reported a profit after tax of Rs -1.88 crore, indicating a significant decline in profitability. Overall, the results reflect a mixed financial performance with strong sales but challenges in profitability.
Oxygenta Pharmaceutical has released its financial results for the quarter ending March 2025, which reveal a notable divergence in performance metrics. The company reported net sales of Rs 49.47 crore, reflecting a year-on-year growth of 368.91%. This figure represents the highest quarterly sales achieved by Oxygenta Pharma in the past five quarters, indicating a strong upward trend in sales performance.In contrast, the company's profit after tax (PAT) for the same quarter was Rs -1.88 crore, which signifies a decline of 124.2% year-on-year. This negative trend in profitability raises concerns regarding the company's financial health, despite the significant growth in sales.
Overall, Oxygenta Pharmaceutical's latest financial results highlight a robust sales performance alongside challenges in profitability, presenting a complex financial landscape for the company. Additionally, the company saw an adjustment in its evaluation, reflecting the mixed nature of its recent financial performance.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
